Ledger.Open graph →
SEC Form D · Amendment · filed July 17, 2025

Renibus Therapeutics, Inc

Offering
$110.9M
Sold
$110.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SOUTHLAKE, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Carlos Guillem · Southlake, TXDirectorD. J. Keyser · Southlake, TXExec · DirectorBhupinder J. Singh · Southlake, TXExec · DirectorJamie J. Donadio · Southlake, TXExecHenrik J. Rasmussen · Southlake, TXDirectorTheodore J. Moskovitz · Austin, TXExecD'Ambrosio Trent · Murray, UTExec · DirectorKevin Thueson · Cheyenne, WYDirectorBrian J. Palmer · Fort Worth, TXDirectorGeorge Quinoy · Woburn, MAExec · DirectorLara A. Cumberland · Cincinnati, OHExec · DirectorVincent Gubitosi · Newton, MADirectorSelim Dogguy · Chicago, ILDirectorPavel Mucha · Chicago, ILExec · DirectorChristopher N. Richardson · Minneapolis, MNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗